Business Standard

Alembic Pharmaceuticals reclassifies Dividend

Image

Capital Market

Of Rs.10 per Share

The Board of Alembic Pharmaceuticals at the meeting held on 4th August 2022 has reclassified the dividend of Rs. 10/- (500%) per equity share for the financial year 2021-22, recommended by them at their meeting held on 2nd May, 2022, into interim dividend for the financial year 2021-22.

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Aug 06 2022 | 10:31 AM IST

Explore News